ACMA Board of Governors
Accreditation Council for Medical Affairs
MD, BCMAS Chief Medical Officer, Head of Global Medical AffairsIpsen Bioscience
PharmD, BCPS, MPH Associate Professor, Clinical & Administrative Services
PharmD Assistant Dean, St. John’s University
PharmD Medical Director, Allergan
MD, BCMAS Senior Vice President, Head of Global Medical Affairs Ipsen Bioscience
Dr. Sotirios Stergiopoulos is Senior Vice President and Head of Global Medical Affairs and a member of the R&D Leadership team at Ipsen BioScience. Sotirios has a extensive experience in directing medical affairs worldwide strategies and plans and a solid expertise in Oncology drug development that includes chemotherapy, immunology drugs and targeted agents across various tumor indications. Sotirios’ past experience includes Vice President, Head of Global Medical Affairs Oncology at Baxalta (now Shire, Cambridge, MA), Executive Medical Director Oncology US Medical Affairs at Celgene Corporation (Summit, NJ), Senior Global Brand Medical Director Oncology at Novartis Pharmaceuticals (East Hanover, NJ) and Director Medical Affairs Oncology at Bayer Healthcare (Montville, NJ).
Dr. Stergiopoulos earned his M.D at the University of Medical Sciences of Poznan, Poland. He completed his residency in Internal Medicine at the Albert Einstein College of Medicine (NY), a clinical and research fellowship in Medical Genetics at Harvard Medical School and a research fellowship at National Institutes of Health where he had received an Intramural Research Training Award.
Dr. Stergiopoulos is currently an Attending Physician in the Department of Internal Medicine at
Jacobi Medical Center, Albert Einstein College of Medicine (NY). In addition, he holds a Masters in Biotechnology Enterprise and Entrepreneurship (MBEE) from The Johns Hopkins University (Baltimore, MD). Sotirios is a Fellow of the New York Academy of Medicine as well as the Royal Society of Medicine (UK). He also is a Member of the American Association of Cancer Research, American Society of Clinical Oncology, and sits on multiple Boards as well as Chairman of Board of A2A Pharmaceuticals, a fragment based computational drug design company.
PharmD, BCPS, MPH
Sam Rasty is an associate professor of Clinical & Administrative Sciences at the California Northstate University College of Pharmacy (CNUCOP). He received his Doctor of Pharmacy degree from the Ferris State University. After graduation, Dr. Rasty completed a Cardiovascular Pharmacotherapy Fellowship at Henry Ford Hospital in Detroit, MI. Dr. Rasty was the clinical coordinator in cardiac and medical intensive care unit at Advocate Christ Medical Center and since 2004 has held various academic, and pharmaceutical industry positions in Medical and Regulatory affairs prior to joining CNUCOP. Most recently Dr. Rasty completed a Master’s degree in public health with a focus in epidemiology. Dr. Rasty’s research primarily focuses on patient health outcomes in cardiovascular pharmacotherapy.
Dr. Kanmaz has served on the faculty at St. John’s University, College of Pharmacy and Health Sciences since 1996 with an interim three-year appointment as an HIV Clinical Science Manager at Abbott Laboratories. During her time at Abbott, she served as the HIV clinical expert for the 5 boroughs of New York, attended national and international HIV/AIDS conferences, developed and presented post-conference educational slide decks, collaborated on phase IV investigator-initiated studies, developed key opinion leaders, participated in regional advisory board meetings, and supported the sales and marketing teams.
She is currently the Assistant Dean for Experiential Pharmacy Education and Associate Clinical Professor in the Department of Clinical Health Professions. She has received several grants directed toward the care of patients with HIV/AIDS and disadvantaged persons in high poverty situations. She is certified as an American Academy of HIV Medicine HIV Expert as well as a certified Smoking Cessation Counselor. Dr. Kanmaz is also an active member of several committees within the American Association of Colleges of Pharmacy10, Experiential Education Special Interest Group.
Dr. Mehul Patel has more than 11 years of experience within the pharmaceutical and medical communications industry. He is currently employed as a Director of Medical Affairs at Allergan, providing medical leadership for the cardiovascular, metabolic and psychiatry portfolio. Responsibilities include developing aligned global medical strategic plans and providing medical input into tactical activities within these therapeutic areas. He as has authored multiple publications and has conducted numerous live CME and non CME lectures. In addition to his current role, Mehul gained his medical affairs/communications experience at PDL BioPharma and at Embryon Inc.. In addition, he spent five years working as a clinical program lead at Biogen Idec where his responsibilities included constructing strategic clinical development plans for drug candidates in the cardiovascular, CNS and immunology therapeutic areas.
Dr. Patel received his doctorate in pharmacy at the Ernest Mario School of Pharmacy (Rutgers University).